Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide

BACKGROUND: Low survival rates in metastatic high-grade osteosarcoma (HGOS) have remained stagnant for the last three decades. This study aims to investigate the role of aminopeptidase N (ANPEP) in HGOS progression and its targeting with a novel lipophilic peptidase-enhanced cytotoxic compound melph...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrgazov, Konstantin, Anderson, Claes, Salzer, Benjamin, Bozsaky, Eva, Larsson, Rolf, Gullbo, Joachim, Lehner, Manfred, Lehmann, Fredrik, Slipicevic, Ana, Kager, Leo, Fryknäs, Mårten, Taschner-Mandl, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391428/
https://www.ncbi.nlm.nih.gov/pubmed/32774473
http://dx.doi.org/10.1177/1758835920937891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391428/
https://www.ncbi.nlm.nih.gov/pubmed/32774473
http://dx.doi.org/10.1177/1758835920937891

Ejemplares similares